FAQs

The 3rd Obesity & Weight Loss Drug Development Summit West is the leading West Coast meeting dedicated to advancing the next generation of obesity and weight loss therapies. Bringing together biopharma leaders across discovery, translational research, clinical development, and commercialization. The summit will take place December 9-10, 2027, in San Diego, CA.

The summit is focused on accelerating the development of safer, more effective obesity therapies. Discussions span the entire drug development lifecycle, from early target identification and translational models through clinical development helping companies bring differentiated therapies to patients faster.

This meeting is designed for professionals working across obesity and metabolic disease drug development, including experts in: Discovery Biology & Pharmacology, Translational Science, Clinical Development, Biomarkers & Imaging, Regulatory Affairs, Medical Affairs, Business Development & Licensing.

Attendees are from a range of high seniorities including Vice Presidents, Heads, and C-Suite executives from biotech, pharma, investors, and solution providers.

Click here to view the sample attendee list.

The Obesity event space is busy, however, unlike broader metabolic health events, the Obesity & Weight Loss Drug Development Summit West is dedicated specifically to the scientific, clinical, and strategic challenges facing obesity drug developers.

The meeting provides:

• A highly focused obesity-specific agenda
• Case studies from leading biopharma innovators
• Dedicated networking with senior decision-makers
• Deep dives into both incretin and next-generation mechanisms
• Opportunities to benchmark strategies with peers across the obesity ecosystem

Click here to view the full event guide and learn more about what you'll gain from the summit.

The summit will explore the biggest challenges and opportunities shaping obesity drug development, from identifying novel targets, advancing combination therapies to preserving muscle mass, improving body composition, and leveraging translational models and biomarkers to de-risk clinical success. Attendees will gain insights into clinical trial design, precision medicine strategies, and approaches to maximizing long-term efficacy, safety, and patient adherence.

Learn more about what's on the agenda here.

You'll meet a highly targeted audience of leaders from biotech, pharma and investment organizations working to advance obesity therapeutics.

The summit is designed to facilitate meaningful discussions with experts responsible for discovering, developing, and commercializing the next wave of obesity treatments and metabolic health innovations.

Click here to view the sample attendee list.

Attendees can connect through 7+ hours of dedicated networking breaks, interactive panel discussions, speed networking sessions & poster presentations

With such a wealth of networking built into the agenda, there are plenty of opportunities to establish new collaborations and strengthen existing relationships.

No. While GLP-1-based therapies remain a key area of the obesity industry, the summit explores emerging mechanisms and next-generation approaches aimed at improving efficacy, tolerability, durability, and patient outcomes.

Topics include combination therapies, amylin analogues, oral therapies, muscle-preservation approaches, energy expenditure targets, precision medicine, and other novel pathways.

View all topics on offer here.

Solution providers can showcase their expertise and connect directly with obesity drug developers looking for support across preclinical research, biomarkers, imaging, clinical operations, manufacturing, regulatory strategy, data analytics, and commercialization.

Sponsorship, exhibition, thought leadership, and networking packages are available to help partners build relationships with key decision-makers throughout the obesity drug development community.

Learn more about sponsorship opportunities here.

Whilst attendance for representatives from biopharma is FREE*

Team discounts are available for service providers looking to send multiple attendees with discounts of 10% discount for 2 attendees, 15% discount for 3 attendees, 20% discount for 4+ attendees.

Additional early booking discounts may also be available. Click here to find out more.

For registration, speaking, sponsorship, or general enquiries, contact the team at: info@hansonwade.com or call +1 617 455 4188. You can also visit https://obesity-weight-loss-west.com/ for the latest event information.

Want to contact a specific member of the team? View the contact us page here.

Yes. Poster sessions provide an opportunity for drug developers and innovators to showcase new data, technologies, and approaches within obesity and metabolic disease drug development.

Information on poster submissions, eligibility, deadlines, and requirements can be found here.

Absolutely. Speakers participate throughout the meeting, including networking sessions, Q&A discussions, panel debates, and informal networking opportunities, giving attendees multiple ways to engage directly with industry leaders.

Explore the full agenda here.